Jaup BH and Norrby A |
Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7771426
|
Isomoto H et al. |
Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. |
2005 |
Am. J. Gastroenterol. |
pmid:16086706
|
Sontag SJ et al. |
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. |
2001 |
Am. J. Gastroenterol. |
pmid:11374672
|
Laine L et al. |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. |
2003 |
Am. J. Gastroenterol. |
pmid:12650788
|
Schaeverbeke T et al. |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. |
2005 |
Am. J. Gastroenterol. |
pmid:16393213
|
Savarino V et al. |
What is the meaning of ranitidine in successful triple-therapy against Helicobacter pylori infection? |
1995 |
Am. J. Gastroenterol. |
pmid:8540537
|
Gisbert JP et al. |
Response to article by Forné et al. |
1996 |
Am. J. Gastroenterol. |
pmid:8561132
|
van Zanten SV and Thompson K |
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection? |
2006 |
Am. J. Gastroenterol. |
pmid:16863548
|
Rokkas T et al. |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. |
2006 |
Am. J. Gastroenterol. |
pmid:16928256
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Coelho LG et al. |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. |
2000 |
Am. J. Gastroenterol. |
pmid:10710099
|
Pilotto A et al. |
In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin. |
2000 |
Am. J. Gastroenterol. |
pmid:10710100
|
Vakil N |
H. pylori treatment: new wine in old bottles? |
2009 |
Am. J. Gastroenterol. |
pmid:19098845
|
Rokkas T et al. |
Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. |
2009 |
Am. J. Gastroenterol. |
pmid:19098844
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Gisbert JP et al. |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. |
2006 |
Am. J. Gastroenterol. |
pmid:16454825
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Ali' A et al. |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. |
1999 |
Am. J. Gastroenterol. |
pmid:10445583
|
Fennerty MB |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. |
1998 |
Am. J. Gastroenterol. |
pmid:9448162
|
Forné M et al. |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. |
1998 |
Am. J. Gastroenterol. |
pmid:9448170
|
Hsu PI et al. |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. |
2005 |
Am. J. Gastroenterol. |
pmid:16279889
|
Vakil N |
Helicobacter pylori: factors affecting eradication and recurrence. |
2005 |
Am. J. Gastroenterol. |
pmid:16279890
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Gisbert JP et al. |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. |
2008 |
Am. J. Gastroenterol. |
pmid:17764498
|
Odaka T et al. |
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. |
2002 |
Am. J. Gastroenterol. |
pmid:11922552
|
Giannini E et al. |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. |
2000 |
Am. J. Gastroenterol. |
pmid:11051345
|
Vakil N and Cutler A |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10235192
|
Scholte GH et al. |
Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy. |
2002 |
Am. J. Gastroenterol. |
pmid:12135019
|
Ozmen MM and Johnson CD |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? |
1995 |
Am. J. Gastroenterol. |
pmid:7661197
|
Savarino V et al. |
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. |
1995 |
Am. J. Gastroenterol. |
pmid:7717343
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
de Boer WA et al. |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9672338
|
Vakil N and Fennerty MB |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. |
1996 |
Am. J. Gastroenterol. |
pmid:8607487
|
Treiber G |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. |
1996 |
Am. J. Gastroenterol. |
pmid:8607488
|
Shaheen N and Grimm IS |
Fulminant hepatic failure associated with clarithromycin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607519
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Parasakthi N and Goh KL |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. |
1995 |
Am. J. Gastroenterol. |
pmid:7872306
|
Kadayifçi A et al. |
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. |
1995 |
Am. J. Gastroenterol. |
pmid:7872307
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Srinivasan R and Minocha A |
Cure of Helicobacter pylori: a hidden curse? |
1997 |
Am. J. Gastroenterol. |
pmid:9399784
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|